The ATPAF1 Knockout Jurkat Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal population of Jurkat T lymphocytes carrying a targeted disruption of the ATPAF1 gene. This loss-of-function model enables investigation of mitochondrial ATP synthase assembly and cellular energy metabolism without clonal selection, preserving the genetic heterogeneity inherent to polyclonal knockout populations.
Jurkat cells are a widely utilized human acute T cell leukemia line that serves as a robust model for T lymphocyte biology, adaptive immune signaling, and metabolic studies. They exhibit rapid proliferation and susceptibility to genetic manipulation, making them suitable for mitochondrial research. Their leukemic origin provides a convenient experimental system for examining cancer cell metabolism and immune cell energetics.
ATPAF1 encodes a critical assembly factor for the F1 catalytic domain of mitochondrial ATP synthase (Complex V). Acting downstream of transcriptional regulators PGC-1??, NRF1, and TFAM, ATPAF1 facilitates proper complex formation with interacting partners such as TMEM70, ATPAF2, and the ATP5B subunit. Disruption of ATPAF1 impairs F1 assembly, leading to defective ATP production and compromised mitochondrial membrane potential, thereby affecting oxidative phosphorylation.
In Jurkat T cells, mitochondrial function is intimately linked to activation, proliferation, and survival. Knockout of ATPAF1 is predicted to disrupt ATP synthase activity, resulting in impaired respiratory capacity and altered immunometabolic profiles. This model may mimic aspects of mitochondrial complex V deficiency disorders, such as mitochondrial encephalopathy and cardiomyopathy, within a tractable cell line. Reconstitution experiments could involve introducing wild-type ATPAF1 or mutant variants to study genotype-phenotype relationships.
Applications include mitochondrial disease modeling, oxidative phosphorylation analysis, and immunometabolism research. The polyclonal population is suitable for functional assays such as Seahorse metabolic flux analysis to measure oxygen consumption rates, ATP bioluminescence assays for ATP levels, flow cytometry with TMRE for membrane potential, and Western blotting for ATP5B or COX IV. Researchers can explore compensatory metabolic shifts or screen for modulators. The ATPAF1 Knockout Jurkat Polyclonal Cells provide a versatile tool for dissecting mitochondrial mechanisms in T cells. For further information, please contact Ascent Research.
